{"id": "1356942363101339648", "creation": 1612355244.0, "user_id": "3233335045", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "quoted": "1356929225727627264", "text": "Britain\u2019s GlaxoSmithKline and German biotech firm CureVac have teamed up in a 150 million euro ($180 million) deal to develop a COVID-19 vaccine from next year that could target several variants with one shot.\n#COVID19 #vaccine #Financial https://t.co/u31L1uQlPY", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#FINANCIAL"]}